The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
The future challenges facing the development of new antimicrobial drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Fleming, A. (1929) · PubMed Central · Cited by 1,647
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
How many antibiotics are produced by the genus Streptomyces ?
Watve, M., Tickoo, R., Jog, M., & Bhole, B. (2001) · Archives of Microbiology · doi:10.1007/s002030100345 · Cited by 923
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Biosynthesis of Complex Polyketides in a Metabolically Engineered Strain of E. coli
Pfeifer, B. A., Admiraal, S. J., Gramajo, H., Cane, D. E., & Khosla, C. (2001) · Science · doi:10.1126/science.1058092 · Cited by 750
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 700
Mutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
Resistance to Antibiotics Mediated by Target Alterations
Spratt, B. G. (1994) · Science · doi:10.1126/science.8153626 · Cited by 674
Moyed, H. S., & Bertrand, K. P. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.768-775.1983 · Cited by 625
Lewis, K. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.3.503-514.2000 · Cited by 616
Harnessing the Biosynthetic Code: Combinations, Permutations, and Mutations
Cane, D. E., Walsh, C. T., & Khosla, C. (1998) · Science · doi:10.1126/science.282.5386.63 · Cited by 603
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
Tuberculosis: a global overview of the situation today.
Sudre, P., ten Dam, G., & Kochi, A. (1992) · Europe PMC (PubMed Central) · Cited by 539
The β-lactamases of Gram-negative bacteria and their rôle in resistance to β-lactam antibiotics
Sykes, R. B., & Matthew, M. (1976) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/2.2.115 · Cited by 536
Mukamolova, G. V., Kaprelyants, A. S., Young, D. I., Young, M., & Kell, D. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8916 · Cited by 448
Animal model pharmacokinetics and pharmacodynamics: a critical review
Andes, D., & Craig, W. A. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00022-5 · Cited by 413
Bactericidal antisense effects of peptide–PNA conjugates
Good, L., Awasthi, S. K., Dryselius, R., Larsson, O., & Nielsen, P. E. (2001) · Nature Biotechnology · doi:10.1038/86753 · Cited by 391
Principles and practice of infectious diseases
Brook, M. G. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90352-f · Cited by 389
Evolution in Health and Disease
Stearns, S. C. (2008) · Cited by 384
RNA expression analysis using a 30 base pair resolution Escherichia coli genome array
Selinger, D. W., Cheung, K. J., Mei, R., Johansson, E. M., Richmond, C. S., Blattner, F. R., Lockhart, D. J., & Church, G. M. (2000) · Nature Biotechnology · doi:10.1038/82367 · Cited by 353
Emergence of vancomycin tolerance in Streptococcus pneumoniae
Novak, R., Henriques, B., Charpentier, E., Normark, S., & Tuomanen, E. (1999) · Nature · doi:10.1038/21202 · Cited by 346
Peltola, H., Kilpi, T., Anttila, M., Peltola, H., & Kilpi, T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92117-x · Cited by 344
Hengge‐Aronis, R. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.511405.x · Cited by 327
Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison, D. A. (2000) · PubMed · Cited by 319
McCune, R. M., Feldmann, F. M., Lambert, H. P., & McDermott, W. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.3.445 · Cited by 310
Killing and regrowth of bacteria in vitro: a review.
Craig, W. A., & Ebert, S. C. (1990) · PubMed · Cited by 303
Basic Mechanisms of Chemotherapy
Mitchison, D. A. (1979) · Chest · doi:10.1378/chest.76.6.771 · Cited by 301
Ball, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.31 · Cited by 290
Mitchison, D. A. (1998) · PubMed · Cited by 288
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Biomimetic synthesis and optimization of cyclic peptide antibiotics
Kohli, R. M., Walsh, C. T., & Burkart, M. D. (2002) · Nature · doi:10.1038/nature00907 · Cited by 287
Quorum sensing and starvation: signals for entry into stationary phase
Lazazzera, B. A. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00072-2 · Cited by 260
The Staphylococcus aureus lrgAB Operon Modulates Murein Hydrolase Activity and Penicillin Tolerance
Groicher, K. H., Firek, B. A., Fujimoto, D. F., & Bayles, K. W. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1794-1801.2000 · Cited by 243
The Relation of p-aminobenzoic Acid to the Mechanism of the Action of Sulphanilamide.
Woods, D. D. (1940) · PubMed Central · Cited by 240
Thornsberry, C., Sahm, D. F., Kelly, L. J., Critchley, I. A., Jones, M. E., Evangelista, A. T., & Karlowsky, J. A. (2002) · Clinical Infectious Diseases · doi:10.1086/324525 · Cited by 222
Lynch, J. P. (2001) · Chest · doi:10.1378/chest.119.2_suppl.373s · Cited by 213
Maximum shields: the assembly and function of the bacterial spore coat
Driks, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02373-9 · Cited by 212
Expression and isolation of antimicrobial small molecules from soil DNA libraries.
MacNeil, I. A., Tiong, C. L., Minor, C., August, P. R., Grossman, T. H., Loiacono, K. A., Lynch, B. A., Phillips, T., Narula, S. S., Sundaramoorthi, R., et al. (2001) · PubMed · Cited by 212
Zhao, X., & Drlica, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338571 · Cited by 210
Bacillus subtilis sporulation and stationary phase gene expression
Phillips, Z. E. V., & Strauch, M. A. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8431-9 · Cited by 206
cAMP-dependent SOS induction and mutagenesis in resting bacterial populations.
Taddei, F., Matic, I., & Radman, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11736 · Cited by 194
Harnessing the Power of the Genome in the Search for New Antibiotics
Rosamond, J., & Allsop, A. (2000) · Science · doi:10.1126/science.287.5460.1973 · Cited by 186
Hu, Y., Mangan, J. A., Dhillon, J., Sole, K. M., Mitchison, D. A., Butcher, P. D., & Coates, A. R. M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.22.6358-6365.2000 · Cited by 181
Self-citationCefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro
O'Callaghan, C. H., SYKES, R. B., Griffiths, A., & Thornton, J. E. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.3.511 · Cited by 176
Scheckler, W. E., Brimhall, D., Buck, A. S., Farr, B. M., Friedman, C., Garibaldi, R. A., Gross, P. A., Harris, J.-A., Hierholzer, W. J., Martone, W. J., et al. (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647779 · Cited by 163
Evolution in Health and Disease
Jones, I. R. (1999) · Heredity · doi:10.1046/j.1365-2540.1999.0561c.x · Cited by 157
The bacterial cell wall as a source of antibacterial targets
Green, D. W. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.1.1 · Cited by 156
Not quite dead enough: on bacterial life, culturability, senescence, and death
Nyström, T. (2001) · Archives of Microbiology · doi:10.1007/s002030100314 · Cited by 142
Thom, S. M., Horobin, R. W., Seidler, E., & Barer, M. R. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb05151.x · Cited by 131
Exploiting current understanding of antibiotic action for discovery of new drugs
Chopra, I., Hesse, L., & O’Neill, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.13.x · Cited by 130
The mode of action of 4-quinolones and possible mechanisms of resistance
Smith, J. T. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_d.21 · Cited by 125
Williams, M. D., Ouyang, T. X., & Flickinger, M. C. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00381.x · Cited by 119
Alonso, A., Campanario, E., & Martínez, J. L. (1999) · Microbiology · doi:10.1099/00221287-145-10-2857 · Cited by 119
Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli
Ashby, M. J., NEALE, J. E., KNOTT, S. J., & Critchley, I. A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.3.443 · Cited by 117
Discovery and development of new antimicrobial agents
Gootz, T. D. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.13 · Cited by 114
Screening of natural products for antimicrobial agents
Silver, L. L., & Bostian, K. A. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01964283 · Cited by 104
Biochemical and genetical approaches to the mechanism of action of penicillin
Spratt, B. G. (1980) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1980.0045 · Cited by 101
The Starvation-Stress Response (SSR) of Salmonella
Spector, M. P. (1998) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60133-2 · Cited by 99
Strategies to minimize the development of antibiotic resistance.
Baquero, F., & Negri, M. C. (1997) · PubMed · Cited by 95
Rodionov, D. G., & Ishiguro, E. E. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.15.4224-4229.1995 · Cited by 91
The Academy of Medical Sciences
Lachmann, P. J. (2018) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-94186-5_9 · Cited by 89
Carriage of Antibiotic‐Resistant Fecal Bacteria in Nepal Reflects Proximity to Kathmandu
Walson, J. L., Marshall, B. M., Pokhrel, B. M., Kafle, K. K., & Levy, S. B. (2001) · The Journal of Infectious Diseases · doi:10.1086/323647 · Cited by 87
Adaptive mutations produce resistance to ciprofloxacin
Riesenfeld, C. S., Everett, M., Piddock, L. J. V., & Hall, B. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2059 · Cited by 87
Constructing Polyketides: From Collie to Combinatorial Biosynthesis
Bentley, R., & Bennett, J. W. (1999) · Annual Review of Microbiology · doi:10.1146/annurev.micro.53.1.411 · Cited by 86
Herbert, D., Paramasivan, C. N., Venkatesan, P., Kubendiran, G., Prabhakar, R., & Mitchison, D. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2296 · Cited by 86
Antibiotic resistance - what can we do?
Bax, R. P., Anderson, R. M., Crew, J., Fletcher, P. S., Johnson, T., Kaplan, E. L., Knaus, B., Kristinsson, K. G., Malek, M., & Strandberg, L. (1998) · Nature Medicine · doi:10.1038/nm0598-545 · Cited by 84
Self-citationGraham, G., Osato, Hoffman, Opekun, Anderson, �., Kwon, & El‐Zimaity (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00770.x · Cited by 75
Pallarés, R., Dick, R., Wenzel, R. P., Adams, J. R., & Nettleman, M. D. (1993) · Infection Control and Hospital Epidemiology · doi:10.1086/646765 · Cited by 74
Addressing antibiotic resistance
Gupta, K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01057-4 · Cited by 74
Pneumococcal resistance patterns in Europe
Pradier, C., Dunais, B., Carsenti-Etesse, H., & Dellamonica, P. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01708553 · Cited by 72
New strategies for antibacterial drug design
KNOWLES, D. J. C. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01128-1 · Cited by 71
Regulating the use of antibiotics in the community
Carbon, C., & Bax, R. P. (1998) · BMJ · doi:10.1136/bmj.317.7159.663 · Cited by 71
Self-citationNational Center for Infectious Diseases
(1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)88138-3 · Cited by 69
Mycobacteria and Human Disease
Grange, J. M. (1996) · Medical Entomology and Zoology · Cited by 66
Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound
Daly, J. S., Eliopoulos, G. M., Willey, S., et al. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1341 · Cited by 66
Current status and future development of antitubercular chemotherapy
Besra, G. S., & Kremer, L. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.8.1033 · Cited by 65
Hu, Y., & Coates, A. R. M. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10780.x · Cited by 65
Self-citationStimulation of the multiplication of Micrococcus luteus by an autocrine growth factor
Mukamolova, G. V., Kormer, S. S., Kell, D. B., & Kaprelyants, A. S. (1999) · Archives of Microbiology · doi:10.1007/s002030050733 · Cited by 64
New antibiotic discovery, novel screens, novel targets and impact of microbial genomics
Allsop, A. E. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80085-4 · Cited by 62
Piddock, L. J. V., & Walters, R. N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.819 · Cited by 62
RECOVERY OF RESISTANCE FACTORS FROM A DRUG-FREE COMMUNITY
Gurney, J. M., Gardner, P., Smith, D., et al. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90664-1 · Cited by 62
Novel targets for the future development of antibacterial agents
McDevitt, D., Payne, D. J., Holmes, D. J., & Rosenberg, M. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.16.x · Cited by 60
What is Finished, and Why Does it Matter: Figure 1.Preprint
Mardis, E. R., McPherson, J. D., Martienssen, R. A., Wilson, R. K., & McCombie, W. R. (2002) · Genome Research · doi:10.1101/gr.032102 · Cited by 59
Mebis, J., Goossens, H., Bruyneel, P., Sion, J. P., Meeus, I., Droogenbroeck, J. V., Schroyens, W., & Berneman, Z. N. (1998) · Leukemia · doi:10.1038/sj.leu.2401158 · Cited by 48
Lutters, M., & Vogt-Ferrier, N. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001535 · Cited by 47
Bonten, M. J. M., Stobberingh, E. E., Philips, J., & Houben, A. W. (1992) · Infection · doi:10.1007/bf01710790 · Cited by 42
Rand, J. D., Danby, S. G., Greenway, D. L. A., et al. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11034.x · Cited by 39
Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics.
TUOMANEN, E. I., & Tomasz, A. (1990) · PubMed · Cited by 39
Strategies to control antibiotic resistance
Cunha, B. A. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.34692 · Cited by 38
Finding drug targets in microbial genomes
Read, T. D., Gill, S. R., Tettelin, H., & Dougherty, B. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01914-6 · Cited by 37
Carbon starvation of Salmonella typhimurium does not cause a general increase of mutation rates
Hughes, D., & Andersson, D. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.21.6688-6691.1997 · Cited by 30
Novelties in the Field of Anti‐Infective Compounds in 1999
Bryskier, A. (2000) · Clinical Infectious Diseases · doi:10.1086/317490 · Cited by 27
Dormancy and Low Growth States in Microbial Disease
(2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546242 · Cited by 26
Safeguarding future antimicrobial options: strategies to minimize resistance
Leclercq, R. (2001) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2001.00050.x · Cited by 25
The prevalence of antibiotic-resistant faecalEscherichia coli in healthy volunteers in Venezuela
van de Mortel, H. J. E., Jansen, E. J. P., Dinant, G., London, N. H. H. J., Prü, E. P., & Stobberingh, E. E. (1998) · Infection · doi:10.1007/bf02962250 · Cited by 18
β-Lactam resistance in normal faecal flora from South Africa
Shanahan, P. M. A., Thomson, C. J., & Amyes, S. G. B. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800058374 · Cited by 17
Antibiotic Use and Escherichia coli Resistance Trends for Quinolones and Cotrimoxazole in Sweden
Farra, A., Skoog, G., Wallén, L., Kahlmeter, G., Kronvall, G., & Sörberg, M. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540110070700 · Cited by 16
Mechanisms of Tuberculosis Chemotherapy
Mitchison, D. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06147.x · Cited by 10
Giacometti, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.5.651 · Cited by 7
Cited by
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Microbial drug discovery: 80 years of progress
Demain, A. L., & Sanchez, S. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.16 · Cited by 1,002
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Metadata
- Authors
- Coates, A., Hu, Y., Bax, R., & Page, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-11
- Volume
- 1
- Issue
- 11
- Pages
- 895-910
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2053696392
- Cited by
- 704
- References
- 110
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.